News

Published on 14 Nov 2022 on Insider Monkey via Yahoo Finance

10 Most Promising Gene Therapy Companies to Watch


Article preview image

In this piece, we will take a look at the ten most promising gene therapy companies to watch. For more companies, take a look at 5 Most Promising Gene Therapy Companies to Watch.

Gene therapy is a revolutionary new technology that has followed the growing advances in computing power. The human body is estimated to be made up of 20,000 genes, and these are the basic programming blocks of its structure. They determine the characteristics that make humans unique and are responsible for a variety of traits such as hair and eye color, height, skin color, and others.

The gene therapy sector also has some of the strongest growth estimates that you are likely to come across. For instance, a report from the research firm Grand View Research believes that this industry will grow at a compounded annual growth rate (CAGR) of 20.4% by 2028 for an estimated value of $10 billion. The research firm attributes this growth to the increase of viral vectors in developing treatments and the growing popularity of gene therapy for treating cancers such as melanoma and B-cell lymphoma. Other diseases that are currently on the radar of gene therapy include muscular atrophy and arterial disease.

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
10 Most Promising Gene Therapy Companies to Watch

In this piece, we will take a look at the ten most promising gene therapy companies to watch. For...

Insider Monkey via Yahoo Finance 14 Nov 2022

Eli Lilly Dividend: Does Eli Lilly Pay Dividends?

Yes, Eli Lilly and Company (NYSE: LLY) pays dividends but there is more to investing in this stoc...

Entrpreneur 27 Oct 2022

The Zacks Analyst Blog Highlights J&J, Roche, Eli Lilly and AbbVie

For Immediate Release Chicago, IL – October 24, 2022 – Zacks.com announces the list of stocks fea...

Zacks via Yahoo Finance 24 Oct 2022

Akouos (AKUS) Surges on $610M Buyout Deal With Eli Lilly

Shares of Akouos AKUS skyrocketed 88.16% after the company announced a buyout agreement for appro...

Zacks via Yahoo Finance 20 Oct 2022

Eli Lilly (LLY) to Buy Hearing Loss Gene Therapy Maker Akouos

Eli Lilly and Company LLY announced a definitive agreement to acquire Boston-based Akouos, AKUS, ...

Zacks via Yahoo Finance 19 Oct 2022

Why Akouos Stock Is on Fire Today

What happened Shares of small-cap gene therapy company Akouos (NASDAQ: AKUS) popped by as much as...

Motley Fool 18 Oct 2022

Why Akouos Shares Are Trading Sharply Higher? Here Are 36 Stocks Moving In Tuesday's Mid-Day Session...

Why Akouos Shares Are Trading Sharply Higher? Here Are 36 Stocks Moving In Tuesday's Mid-Day Sess...

Investing.com 18 Oct 2022

Eli Lilly to acquire Akouos for up to about $610 million and develop gene therapies for hearing loss

Eli Lilly and Co. said Tuesday it has entered an agreement to acquire Akouos Inc. a company devel...

MarketWatch 18 Oct 2022

Akouos, Inc. (AKUS) Upgraded to Strong Buy: Here's Why

Akouos, Inc. (AKUS) could be a solid choice for investors given its recent upgrade to a Zacks Ran...

Zacks via Yahoo Finance 10 Oct 2022

FDA Clears Akouos' Gene Therapy Trial For Genetic Form Of Hearing Loss

The FDA has signed off Akouos Inc's (NASDAQ: AKUS) Investigational New Drug application to initia...

Benzinga via Yahoo Finance 13 Sep 2022